471 related articles for article (PubMed ID: 1682478)
1. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
Borg C; Mondot S; Mestre M; Cavero I
J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
[TBL] [Abstract][Full Text] [Related]
2. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
Magnon M; Durand I; Cavero I
J Pharmacol Exp Ther; 1994 Mar; 268(3):1411-8. PubMed ID: 7908056
[TBL] [Abstract][Full Text] [Related]
3. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
Greenberg SS; Cantor E; Ho E; Walega M
J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.
Meisheri KD; Cipkus-Dubray LA; Hosner JM; Khan SA
J Cardiovasc Pharmacol; 1991 Jun; 17(6):903-12. PubMed ID: 1714013
[TBL] [Abstract][Full Text] [Related]
6. Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
Pérez-Vizcaíno F; Cogolludo AL; Villamor E; Tamargo J
Br J Pharmacol; 1998 Mar; 123(5):847-54. PubMed ID: 9535012
[TBL] [Abstract][Full Text] [Related]
7. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
Fujiwara T; Angus JA
Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
[TBL] [Abstract][Full Text] [Related]
8. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
Eltze M
Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
[TBL] [Abstract][Full Text] [Related]
9. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
Satoh K; Yamada H; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
[TBL] [Abstract][Full Text] [Related]
10. Regional differences in the vasorelaxant effects of nicorandil and amlodipine on isolated porcine coronary arteries.
Tankó LB; Mikkelsen EO; Frøbert O; Bagger JP
Fundam Clin Pharmacol; 1998; 12(1):50-7. PubMed ID: 9523184
[TBL] [Abstract][Full Text] [Related]
11. Nicorandil activates glibenclamide-sensitive K+ channels in smooth muscle cells of pig proximal urethra.
Teramoto N; Brading AF
J Pharmacol Exp Ther; 1997 Jan; 280(1):483-91. PubMed ID: 8996232
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
Kwan YW; To KW; Lau WM; Tsang SH
Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of coronary guanylate cyclase by nicorandil (SG-75) as a mechanism of its vasodilating action.
Schmidt K; Reich R; Kukovetz WR
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):43-53. PubMed ID: 2858501
[TBL] [Abstract][Full Text] [Related]
14. Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.
Kukovetz WR; Holzmann S; Braida C; Pöch G
J Cardiovasc Pharmacol; 1991 Apr; 17(4):627-33. PubMed ID: 1711631
[TBL] [Abstract][Full Text] [Related]
15. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
[TBL] [Abstract][Full Text] [Related]
16. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
17. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
Abe S; Nishimura J; Nakamura M; Kanaide H
J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
[TBL] [Abstract][Full Text] [Related]
18. The inhibitory mechanisms of nicorandil in isolated rat urinary bladder and femoral artery.
Zhou Q; Satake N; Shibata S
Eur J Pharmacol; 1995 Jan; 273(1-2):153-9. PubMed ID: 7737309
[TBL] [Abstract][Full Text] [Related]
19. Relationship between cyclic guanosine monophosphate accumulation and relaxation of canine trachealis induced by nitrovasodilators.
Zhou HL; Torphy TJ
J Pharmacol Exp Ther; 1991 Sep; 258(3):972-8. PubMed ID: 1679854
[TBL] [Abstract][Full Text] [Related]
20. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
